Haven Capital Group, Inc. has filed a Form 13F-HR disclosing its equity holdings as of September 30, 2026. The filing lists 39 separate positions held by the firm during the reported quarter.
The portfolio is dominated by large-cap technology and healthcare names. The largest holding is NVIDIA Corporation, for which the firm holds 11,213,761 shares. Other significant positions include Apple Inc. with 13,694,781 shares, Alphabet Inc. Class A with 8,453,013 shares, and Microsoft Corporation with 5,027,446 shares.
Healthcare and biotechnology companies also represent a substantial portion of the portfolio. Eli Lilly & Co. is held at 2,925,098 shares, while Iovance Biotherapeutics Inc. is held at 87,649 shares. The filing also lists positions in Abbott Laboratories, Bristol-Myers Squibb Co., and Edwards Lifesciences Corp.
The filing indicates that all positions are held as sole voting power and sole dispositive power, with no shared voting or investment authority reported.
